News
Stories and articles featuring PCI, our partners, and Penn-affiliated spinout companies
Philadelphia Life Sciences Jobs Being Filled More by Women Than Men, Study Finds
The number of jobs held by women in the Philadelphia region's life sciences industry is growing at a faster rate than jobs held by men, according to a new report featured in the Philadelphia Business
Future mRNA Vaccine Applications Highlighted
The New York Post recently published an article discussing future applications of mRNA, including vaccinations against tuberculosis, malaria, high cholesterol, HIV, and more.
Penn Startups Win Several PACT Enterprise Awards
viTToria Biotherapeutics and Exyn Technologies, both startups co-founded by Penn faculty, won recent awards from the Philadelphia Alliance for Capital and Technologies.
4D Molecular Therapeutics (4DMT) Acquires Rights to Penn Medicine Invented Technology from Aevitas Therapeutics
Penn spinout Aevitas Therapeutics recently executed an asset purchase agreement with California-based biotechnology company 4D Molecular Therapeutics (4DMT).
Adult Schizophrenia drug based on IP developed at Penn wins FDA approval
Teva Pharmaceuticals and MedinCell recently received approval from the U.S. Food and Drug Administration (FDA) for UZEDY™ (risperidone).
Cabaletta Bio Receives FDA Fast Track Designation for CABA-201 Drug to Target Autoimmune Diseases
Cabaletta Bio received Fast Track Designation from the U.S. Food and Drug Administration (FDA) for its drug CABA-201.
Verismo Therapeutics Activates its STAR-101 Clinical Trial to Evaluate Investigational Drug SynKIR-110
Penn spinout Verismo Therapeutics, which focuses on CAR T-cell therapy for solid tumors, has activated its STAR-101 Phase 1 clinical trial at Penn.
PCI’s Carter Caldwell Is Interviewed on Launching a Startup
PCI’s Carter Caldwell, program director for the Penn Medicine Co-Investment Program, discussed his entrepreneurial career and shared advice for others looking to start businesses.
Penn Today Highlights How Penn Research Powers Numerous FDA-approved Treatments
From CAR-T therapy to the mRNA covid-19 vaccine, the list of Penn-linked FDA approvals has been growing with each passing year.
PCI Participates in Philly Tech Week and Hosts “The Future of Wearable Technology”
On May 9th, PCI and the Philadelphia Alliance for Capital and Technologies (PACT) co-hosted the event "The Future of Wearable Technology" at the Pennovation Center as part of Philly Tech Week 2023